May 22, 2018
Biosciences Researchers and Pharma/Medical Device Entrepreneurs, you want to hear what Rainer Fischer, PhD, has to say. He's done it before and he will do it again - this time in Indiana. The team Dr. Fischer is building is made up of the best leadership and scientific talent in the world - and they are just getting started. IBRI and Dr. Fischer plan to see to it that Indiana will be the home of groundbreaking innovations in healthcare. In our conversation, Dr. Fischer describes his diverse and impactful background. Though he is quick to give deserved credit to the people around him, it is clear that his leadership attracts the best talent and inspires meaningful action. Hear how he does it in this engaging conversation. Stick around until the end to hear the real story behind his personal time with famed rock-and-rollers The Scorpions!
Rainer Fischer, PhD, is the Chief Executive Officer and Chief Scientific and Innovation Officer of the Indiana Biosciences Research Institute. He joined the IBRI in April of 2017 as the Chief Scientific and Innovation Officer. In October that same year, he also was named Chief Executive Officer. Fischer spent 19 years building and leading the Fraunhofer Institute for Molecular Biology and Applied Ecology (IME) in Aachen, Schmallenberg, Muenster, Giessen, Frankfurt and Hamburg in Germany, and its subsidiaries in Newark, Delaware, USA and Santiago, Chile. The Fraunhofer-Gesellschaft is the largest applied science research organization in Europe, with applied research aimed at addressing issues of health, security, production technology, energy, materials, and the environment.
During his time at the Fraunhofer-Gesellschaft, Fischer grew the IME Institute from 40 to 680 employees, raised with his team almost one billion euro in extramural research funding, and established international collaborations with academia and industry in more than 25 countries. Those collaborations include many of the leading global companies in the biotechnology, pharmaceuticals, agriculture, food and chemical industries.
Fischer also served as Department Head of the Institute for Molecular Biotechnology at RWTH Aachen University where he was awarded a Distinguished Professorship in 2015. He created the department, co-establishing both undergraduate and graduate programs that have matriculated more than 500 students including 115 graduated PhD students. Fischer is a prolific presenter and has published more than 340 peer reviewed scientific papers that have been cited over 16,000 times. In addition to his academic and leadership experience, he co-founded five biotechnology startups, holds over 60 issued patents and has more than 120 patent applications pending. Fischer also holds a second Professorship at Maastricht University, Netherlands where he co-founded the Aachen-Maastricht-Institute-of-Biobased-Materials (AMIBM) in 2015. (bio copied from http://www.indianabiosciences.org/team/?specialty=Leadership)
To learn more about Dr. Fischer and the Indiana Biosciences Research Institute, visit www.indianabiosciences.org